Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
TherapeuticsMD, an innovative, leading women’s healthcare company, today announced that it has entered into definitive […]
Positive Impact of Blue Light Cystoscopy on Recurrence in Bladder Cancer Presented at the Annual SUO Meeting
Photocure ASA, The Bladder Cancer Company, announces that new evidence was presented at the 22nd […]
Telix Announces Executive Leadership Appointments
Telix Pharmaceuticals has announced several key executive leadership appointments and promotions, reflecting the increased commercial […]
JelloX Biotech Leads Research in 3D Cancer Pathology as NCI Explores Potential
JelloX Biotech is celebrating a robust year of research and product development milestones while showcasing […]
Tampa General Hospital's Cancer Institute Awarded Coveted Accreditation from Commission on Cancer
Tampa General Hospital (TGH), the primary teaching hospital for the USF Health Morsani College of […]
Tevogen Bio to Develop T Cell Therapies for Treatment of Epstein-Barr Virus Related Cancers and Multiple Sclerosis
Tevogen Bio, a late-stage clinical biotechnology company specializing in the development of cellular immunotherapies in […]
Syndax Pharmaceuticals Announces Appointment of Steve Sabus as Chief Commercial Officer
Syndax Pharmaceuticals, a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, has announced […]
Inszone Insurance Services Completes Acquisition of Kirsch Insurance Group
Inszone Insurance Services, a rapidly growing, national provider of benefits, personal and commercial lines insurance, […]
Nemysis and Faran S.A. Sign Agreement to Cooperate for the Development of Endopeptidase E40 for Celiac Disease
Nemysis Ltd has announced a Strategic Cooperation with Faran S.A., a leading Greek pharma company, […]
Focus-X Therapeutics Successfully Reached an Acquisition Agreement with Full-Life Technologies
Focus-X Therapeutics, a nuclide drug company that was invested in and incubated by Viva Biotech, […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more